Current Knowledge of Progestin-Only Pills
Since the 1960s, contraceptive pills have been at the service of humanity. They are one of the innovations that have contributed the most to the changing role of women in society and to women achieving the role they play today. Combined oral contraceptives (COCs) opened up opportunities to increase...
- Autores:
-
Monterrosa-Castro, Álvaro
Redondo-Mendoza, Velia
Monterrosa-Blanco, Angelica
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2021
- Institución:
- Universidad de Cartagena
- Repositorio:
- Repositorio Universidad de Cartagena
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unicartagena.edu.co:11227/19635
- Acceso en línea:
- https://hdl.handle.net/11227/19635
- Palabra clave:
- 3. Ciencias Médicas y de la Salud
Oral contraceptives
Progestogens
Progestins
Progestin-only pills
Contraceptive effectiveness
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc/4.0/
| id |
UCART2_eb60738fa7fcf0c3e5ec4124c6d162d4 |
|---|---|
| oai_identifier_str |
oai:repositorio.unicartagena.edu.co:11227/19635 |
| network_acronym_str |
UCART2 |
| network_name_str |
Repositorio Universidad de Cartagena |
| repository_id_str |
|
| dc.title.eng.fl_str_mv |
Current Knowledge of Progestin-Only Pills |
| title |
Current Knowledge of Progestin-Only Pills |
| spellingShingle |
Current Knowledge of Progestin-Only Pills 3. Ciencias Médicas y de la Salud Oral contraceptives Progestogens Progestins Progestin-only pills Contraceptive effectiveness ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades |
| title_short |
Current Knowledge of Progestin-Only Pills |
| title_full |
Current Knowledge of Progestin-Only Pills |
| title_fullStr |
Current Knowledge of Progestin-Only Pills |
| title_full_unstemmed |
Current Knowledge of Progestin-Only Pills |
| title_sort |
Current Knowledge of Progestin-Only Pills |
| dc.creator.fl_str_mv |
Monterrosa-Castro, Álvaro Redondo-Mendoza, Velia Monterrosa-Blanco, Angelica |
| dc.contributor.author.none.fl_str_mv |
Monterrosa-Castro, Álvaro Redondo-Mendoza, Velia Monterrosa-Blanco, Angelica |
| dc.contributor.researchgroup.none.fl_str_mv |
Grupo de investigación Salud de la Mujer |
| dc.subject.ocde.none.fl_str_mv |
3. Ciencias Médicas y de la Salud |
| topic |
3. Ciencias Médicas y de la Salud Oral contraceptives Progestogens Progestins Progestin-only pills Contraceptive effectiveness ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades |
| dc.subject.proposal.eng.fl_str_mv |
Oral contraceptives Progestogens Progestins Progestin-only pills Contraceptive effectiveness |
| dc.subject.ods.none.fl_str_mv |
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades |
| description |
Since the 1960s, contraceptive pills have been at the service of humanity. They are one of the innovations that have contributed the most to the changing role of women in society and to women achieving the role they play today. Combined oral contraceptives (COCs) opened up opportunities to increase knowledge about the effects of estrogens and progestins in the female organism. The overall results of this evolution were progestin-only contraceptives in general and estrogen-free oral contraceptives as progestin-only pills (POPs) in particular. To identify the position currently held by POPs, a bibliographic review was carried out in the following databases: PubMed, ScienceDirect, EBSCOhost, OvidSP, Embase, and SciELO in Spanish. POPs have evolved notably from restricted use only during breastfeeding to a broader context. The absence of estrogen in the pill currently offers more advantages than disadvantages. The recent introduction of POP containing 4.0 mg of drospirenone, administered in a 24/4-day regimen, offers better cycle control than previous POPs, as it allows much more predictable bleedings and the same contraceptive efficacy as COCs. Hormonal contraception use continues to grow. The options to regulate reproduction are numerous, and users have a greater number of options to choose the one that suits their needs and comforts. Health professionals must provide high-quality contraceptive counseling, offering all available tools, including POPs. |
| publishDate |
2021 |
| dc.date.issued.none.fl_str_mv |
2021-08-25 |
| dc.date.accessioned.none.fl_str_mv |
2025-06-12T16:01:34Z |
| dc.date.available.none.fl_str_mv |
2025-06-12T16:01:34Z |
| dc.type.none.fl_str_mv |
Artículo de revista |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.content.none.fl_str_mv |
Text |
| dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.issn.none.fl_str_mv |
2516-3507 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/11227/19635 |
| dc.identifier.eissn.none.fl_str_mv |
2516-3507 |
| identifier_str_mv |
2516-3507 |
| url |
https://hdl.handle.net/11227/19635 |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournal.none.fl_str_mv |
Electronic Journal of General Medicine |
| dc.relation.citationendpage.none.fl_str_mv |
12 |
| dc.relation.citationissue.none.fl_str_mv |
6 |
| dc.relation.citationstartpage.none.fl_str_mv |
1 |
| dc.relation.citationvolume.none.fl_str_mv |
18 |
| dc.relation.references.none.fl_str_mv |
Black A, Guilbert E. Canadian Contraceptive Consensus. Clinical practice guideline. J Obstet Gynaecol Can. 2016;38(3):279-300. https://doi.org/10.1016/j.jogc.2015.12. 003 PMid:27106200 Edwards L. An update and oral contraceptive options. Formulary. 2004;39:104-21. Hall KS, Trussell J, Schwarz EB. Progestin-only contraceptive pill use among women in the United States. Contraception. 2012;86:653-8. https://doi.org/10.1016/ j.contraception.2012.05.003 PMid:22682722 PMC3440515 Duijkers IJM, Heger-Mahn D, Drouin D, Colli E, Skouby S. Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake. Contraception. 2016;93(4):303-9. https://doi.org/10.1016/j.contraception. 2015.12.007 PMid:26708301 Milsom I, Korver T. Ovulation incidence with oral contraceptives: a literature review. J Fam Plann Reprod Health Care. 2008;34:237-46. https://doi.org/10.1783/ 147118908786000451 PMid:18854069 |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ |
| dc.rights.license.none.fl_str_mv |
Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) |
| dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Modestum |
| dc.publisher.place.none.fl_str_mv |
Inglesa |
| publisher.none.fl_str_mv |
Modestum |
| dc.source.none.fl_str_mv |
https://www.ejgm.co.uk/article/current-knowledge-of-progestin-only-pills-11217 |
| institution |
Universidad de Cartagena |
| bitstream.url.fl_str_mv |
https://repositorio.unicartagena.edu.co/bitstreams/3fd2e227-0081-4928-b6e8-4c49212266ca/download https://repositorio.unicartagena.edu.co/bitstreams/086b79eb-072d-4b16-a0a3-66dcfaeaec18/download https://repositorio.unicartagena.edu.co/bitstreams/e5f5b6a2-f796-4fb4-a302-dea60255f6d1/download https://repositorio.unicartagena.edu.co/bitstreams/684c8189-5120-4c35-8905-8b083c3db7b6/download |
| bitstream.checksum.fl_str_mv |
264b38b31f563deaaa8c572917c82007 64eb6cdbc122cfe492fa78c8434a0f6b 624dca8716086861afdbc812af251fec dbeb2974a27c998477286d80e4f9a708 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Biblioteca Digital Universidad de Cartagena |
| repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
| _version_ |
1837099101709139968 |
| spelling |
Monterrosa-Castro, ÁlvaroRedondo-Mendoza, VeliaMonterrosa-Blanco, AngelicaGrupo de investigación Salud de la Mujer2025-06-12T16:01:34Z2025-06-12T16:01:34Z2021-08-252516-3507https://hdl.handle.net/11227/196352516-3507Since the 1960s, contraceptive pills have been at the service of humanity. They are one of the innovations that have contributed the most to the changing role of women in society and to women achieving the role they play today. Combined oral contraceptives (COCs) opened up opportunities to increase knowledge about the effects of estrogens and progestins in the female organism. The overall results of this evolution were progestin-only contraceptives in general and estrogen-free oral contraceptives as progestin-only pills (POPs) in particular. To identify the position currently held by POPs, a bibliographic review was carried out in the following databases: PubMed, ScienceDirect, EBSCOhost, OvidSP, Embase, and SciELO in Spanish. POPs have evolved notably from restricted use only during breastfeeding to a broader context. The absence of estrogen in the pill currently offers more advantages than disadvantages. The recent introduction of POP containing 4.0 mg of drospirenone, administered in a 24/4-day regimen, offers better cycle control than previous POPs, as it allows much more predictable bleedings and the same contraceptive efficacy as COCs. Hormonal contraception use continues to grow. The options to regulate reproduction are numerous, and users have a greater number of options to choose the one that suits their needs and comforts. Health professionals must provide high-quality contraceptive counseling, offering all available tools, including POPs.application/pdfengModestumInglesaElectronic Journal of General Medicine126118Black A, Guilbert E. Canadian Contraceptive Consensus. Clinical practice guideline. J Obstet Gynaecol Can. 2016;38(3):279-300. https://doi.org/10.1016/j.jogc.2015.12. 003 PMid:27106200Edwards L. An update and oral contraceptive options. Formulary. 2004;39:104-21.Hall KS, Trussell J, Schwarz EB. Progestin-only contraceptive pill use among women in the United States. Contraception. 2012;86:653-8. https://doi.org/10.1016/ j.contraception.2012.05.003 PMid:22682722 PMC3440515Duijkers IJM, Heger-Mahn D, Drouin D, Colli E, Skouby S. Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake. Contraception. 2016;93(4):303-9. https://doi.org/10.1016/j.contraception. 2015.12.007 PMid:26708301Milsom I, Korver T. Ovulation incidence with oral contraceptives: a literature review. J Fam Plann Reprod Health Care. 2008;34:237-46. https://doi.org/10.1783/ 147118908786000451 PMid:18854069https://creativecommons.org/licenses/by-nc/4.0/Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccesshttps://www.ejgm.co.uk/article/current-knowledge-of-progestin-only-pills-11217Current Knowledge of Progestin-Only PillsArtículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/article3. Ciencias Médicas y de la SaludOral contraceptivesProgestogensProgestinsProgestin-only pillsContraceptive effectivenessODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edadeshttps://www.grupodeinvestigacionsaluddelamujer.com/ORIGINAL94_current-knowledge-of-progestin-only-pills-11217 (1).pdf94_current-knowledge-of-progestin-only-pills-11217 (1).pdfapplication/pdf337911https://repositorio.unicartagena.edu.co/bitstreams/3fd2e227-0081-4928-b6e8-4c49212266ca/download264b38b31f563deaaa8c572917c82007MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81802https://repositorio.unicartagena.edu.co/bitstreams/086b79eb-072d-4b16-a0a3-66dcfaeaec18/download64eb6cdbc122cfe492fa78c8434a0f6bMD52TEXT94_current-knowledge-of-progestin-only-pills-11217 (1).pdf.txt94_current-knowledge-of-progestin-only-pills-11217 (1).pdf.txtExtracted texttext/plain77393https://repositorio.unicartagena.edu.co/bitstreams/e5f5b6a2-f796-4fb4-a302-dea60255f6d1/download624dca8716086861afdbc812af251fecMD53THUMBNAIL94_current-knowledge-of-progestin-only-pills-11217 (1).pdf.jpg94_current-knowledge-of-progestin-only-pills-11217 (1).pdf.jpgGenerated Thumbnailimage/jpeg15021https://repositorio.unicartagena.edu.co/bitstreams/684c8189-5120-4c35-8905-8b083c3db7b6/downloaddbeb2974a27c998477286d80e4f9a708MD5411227/19635oai:repositorio.unicartagena.edu.co:11227/196352025-06-13 05:02:30.086https://creativecommons.org/licenses/by-nc/4.0/open.accesshttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.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 |